Skip to content
Open access · CC-BY via OpenAlex

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin

Tae‐In Kam, Hyejin Park, Shih-Ching Chou, Jonathan G. Van Vranken, Melanie J. Mittenbühler, Hyeonwoo Kim, Mu A, Yu Ree Choi, Devanik Biswas, Justin L. Wang, Yu Jung Shin, Alexis K Loder, Senthilkumar S. Karuppagounder, Christiane D. Wrann, Valina Lynn Dawson

Proceedings of the National Academy of Sciences · 2022 · ▲ 137 citations

Abstract

Physical activity provides clinical benefit in Parkinson's disease (PD). Irisin is an exercise-induced polypeptide secreted by skeletal muscle that crosses the blood-brain barrier and mediates certain effects of exercise. Here, we show that irisin prevents pathologic α-synuclein (α-syn)-induced neurodegeneration in the α-syn preformed fibril (PFF) mouse model of sporadic PD. Intravenous delivery of irisin via viral vectors following the stereotaxic intrastriatal injection of α-syn PFF cause a reduction in the formation of pathologic α-syn and prevented the loss of dopamine neurons and lowering of striatal dopamine. Irisin also substantially reduced the α-syn PFF-induced motor deficits as assessed behaviorally by the pole and grip strength test. Recombinant sustained irisin treatment of primary cortical neurons attenuated α-syn PFF toxicity by reducing the formation of phosphorylated serine 129 of α-syn and neuronal cell death. Tandem mass spectrometry and biochemical analysis revealed that irisin reduced pathologic α-syn by enhancing endolysosomal degradation of pathologic α-syn. Our findings highlight the potential for therapeutic disease modification of irisin in PD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1073/pnas.2204835119
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Kam, T., Park, H., Chou, S., Vranken, J.G.V., Mittenbühler, M.J., Kim, H., A, M., Choi, Y.R., Biswas, D., Wang, J.L., Shin, Y.J., Loder, A.K., Karuppagounder, S.S., Wrann, C.D., Dawson, V.L., Spiegelman, B.M., &amp; Dawson, T.M. (2022). Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.2204835119
Vancouver
Kam T, Park H, Chou S, Vranken JGV, Mittenbühler MJ, Kim H, et al. Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin. Proceedings of the National Academy of Sciences. 2022. doi:10.1073/pnas.2204835119.
BibTeX
@article{taein2022Amelio, title = {Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin}, author = {Tae‐In Kam and Hyejin Park and Shih-Ching Chou and Jonathan G. Van Vranken and Melanie J. Mittenbühler and Hyeonwoo Kim and Mu A and Yu Ree Choi and Devanik Biswas and Justin L. Wang and Yu Jung Shin and Alexis K Loder and Senthilkumar S. Karuppagounder and Christiane D. Wrann and Valina Lynn Dawson and Bruce M. Spiegelman and Ted M. Dawson}, journal = {Proceedings of the National Academy of Sciences}, year = {2022}, doi = {10.1073/pnas.2204835119}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings